The Medical Advisor

Despite  trillions spent on cancer research  ( The Lancet Oncology ), cancer still  kills around 10 million people a year  ( WHO ) and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide.   Credit:  Statista Breast, lung and colon cancer are among the most common, while the number of new cancer cases annually is expected to grow by more than 75% between 2022 and 2050. As we enter 2026, several groundbreaking therapies and innovations—including personalized vaccines, gene-editing technologies, repurposed drugs, and alternative cancer treatments —are reshaping cancer care. Here are some of the most promising breakthroughs to watch for this year: 1. Next-Generation Immunotherapy Perhaps the most transformative breakthrough in modern oncology has been the rise of immunotherapy—a set of treatm...

Why Metabolism Is the Missing Link in Modern Medicine Cancer prevention, longevity, and metabolic health are usually discussed as separate domains. Oncology focuses on mutations. Aging research focuses on senescence and epigenetics. Metabolic health is reduced to weight, glucose, or cholesterol. This siloed thinking misses a deeper unifying driver. The common thread connecting cancer risk, cancer outcomes, and biological aging is metabolic signaling —specifically insulin resistance and mitochondrial dysfunction. This article lays out a single, coherent framework: Insulin resistance drives mitochondrial dysfunction, which erodes metabolic flexibility. That environment accelerates aging and creates fertile ground for cancer. 1. Insulin Resistance Is Not a Blood Sugar Problem Insulin resistance (IR) is often framed as a pre-diabetic condition. In reality, it is a whole-cell signaling disorder . When insulin signaling is impaired: Cells fail to take up glucose efficiently Circulating insul...

Table of Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories  (115 cases) Brain Cancer (including Glioblastoma) (122 cases) Bile Duct Cancer (Cholangiocarcinoma)  (4 cases) Bladder Cancer Success Stories  (including kidney cancer) (32 cases) Cervical Cancer  (6 cases) Colorectal Cancer  (including Appendix cancer) (59 cases) Esophageal and Stomach cancer (23 cases) Endometrial Cancer (11 cases) Gastric (Stomach) cancer (see  Esophageal and Stomach Cancer ) (22 cases) Head and Neck Cancer (16 cases) Kidney Cancer Case Series  (including urinary (urothelial) bladder cancer) (32 cases) Liver Cancer (HepatoCellular Cancer)  (3 cases) Lung Cancer (43 cases) Leukemia (10 cases) Lymphoma (23 cases) Melanoma (refer to Skin Cancer ) ...